PRIVATE GENERIC DRUG DISPENSING INCENTIVES SHOULD INCLUDE REDUCTION IN CONSUMER CO-PAY AS WELL AS HIGHER PHARMACIST FEES, REVCO EXEC TELLS NAPM

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".